Multicenter Open-label Study to Evaluate the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine for the Treatment of Children and Adolescents Newly Diagnosed With Ulcerative Colitis.

Trial Profile

Multicenter Open-label Study to Evaluate the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine for the Treatment of Children and Adolescents Newly Diagnosed With Ulcerative Colitis.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 May 2017

At a glance

  • Drugs Mesalazine (Primary) ; Corticosteroids; Prednisone
  • Indications Ulcerative colitis
  • Focus Biomarker; Therapeutic Use
  • Acronyms PROTECT
  • Most Recent Events

    • 12 May 2017 Planned End Date changed from 1 Jun 2017 to 1 Oct 2017.
    • 30 Jul 2012 Actual initiation date (Jun 2012) added as reported by ClinicalTrials.gov.
    • 01 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top